Sign in

CIK 0001863127 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Tyra Biosciences, Inc.

Sign in to watch
Ticker
TYRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831476348
Phone
(619) 728-4760
Business address
2656 STATE STREET, CARLSBAD, CA, 92008
  1. 4 Open-market sale Director sold 14,295 shares at $36.97 ($528,506)
  2. 4 Grant or award Chief Financial Officer acquired 1,376 shares (grant or award)
  3. 4 Grant or award President and CEO acquired 1,463 shares (grant or award)
  4. 4 Planned sale Chief Discovery Officer sold 8,000 shares at an average $32.87 ($262,965)
  5. 4 Planned sale Chief Discovery Officer sold 8,000 shares at an average $28.52 ($228,186)
  6. 4 Planned sale Director sold 10,000 shares at $25.00 ($250,000)
  7. 4 Planned sale Chief Discovery Officer sold 8,000 shares at $22.64 ($181,159)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Planned sale Director sold 246,871 shares at $20.25 ($5,000,026)
  11. 4 Planned sale Chief Operating Officer sold 125,589 shares at an average $16.17 ($2,030,923)
  12. 4 Planned sale Chief Operating Officer sold 131,411 shares at an average $16.04 ($2,108,067)
  13. 4 Grant or award Chief Financial Officer acquired 701 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market sale Director sold 9,578 shares at an average $9.78 ($93,700)
  19. 4 Open-market buy Director bought 163,287 shares at an average $10.19 ($1,664,700)
  20. 4 Open-market sale Director sold 51,814 shares at an average $10.32 ($534,563)

Page 2 of 11 · 203 filings